GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $45,010,000 | -11.1% | 390,000 | -25.0% | 7.31% | +60.5% |
| Q3 2020 | $50,645,000 | -8.3% | 520,232 | +15.6% | 4.56% | +3.2% |
| Q2 2020 | $55,224,000 | +40.1% | 450,000 | 0.0% | 4.41% | +7.2% |
| Q1 2020 | $39,407,000 | +166.0% | 450,000 | +217.6% | 4.12% | +219.1% |
| Q4 2019 | $14,814,000 | +49.6% | 141,683 | +88.9% | 1.29% | -23.6% |
| Q4 2017 | $9,901,000 | +213.4% | 75,000 | +215.1% | 1.69% | +109.6% |
| Q3 2016 | $3,159,000 | -54.5% | 23,800 | -76.2% | 0.81% | -72.3% |
| Q4 2015 | $6,944,000 | -62.7% | 100,000 | -50.9% | 2.91% | -60.4% |
| Q3 2015 | $18,621,000 | – | 203,800 | – | 7.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |